-
The Definitive Thrombosis Update
CME Drs Kakkar, Fox, Verheugt, and Büller present the latest clinical trial data on novel, oral anticoagulants across the spectrum of thromboembolic diseases.
Medscape Education Cardiology, May 2012
-
Tailoring Anticoagulation Therapy to Patient Needs: Evaluating Stroke Risk in AF
CME Drs Camm and Bode discuss the practicalities of using novel anticoagulants for the prevention of AF-related stroke.
Medscape Education Cardiology, May 2012
-
Putting the AF-Stroke Prevention Trials Into Perspective: Looking at the Big Picture
CME Drs Turpie, Califf, Granger, and Wallentin discuss how novel oral anticoagulants are being used in the prevention of AF-related stroke.
Medscape Education Cardiology, April 2012
-
Position Paper Addresses New Anticoagulants in AF and ACS
CME/CE A committee from the European Society of Cardiology Working Group on Thrombosis has issued a position paper on the new oral anticoagulants for atrial fibrillation and acute coronary syndrome.
Heartwire CME, April 2012
-
Statins Before Cardiac Surgery May Improve Some Clinical Outcomes
CME Statins given before cardiac surgery significantly reduced the risk for postoperative atrial fibrillation and significantly shortened the length of stay in the intensive care unit.
Heartwire CME, April 2012
-
Warfarin Still Rules in Stroke Prevention in Patients With AF
CME/CE meta-analysis shows that patients with atrial fibrillation taking warfarin for stroke prevention have a considerably lower risk for stroke or embolism than found in a previous meta-analysis.
Medscape Education Clinical Briefs, April 2012
-
Rheumatoid Arthritis Linked With Increased Risks for AF, Stroke
CME A new study shows that patients with rheumatoid arthritis have a 40% increased risk for atrial fibrillation and a 30% increased risk of stroke vs those without rheumatoid arthritis.
Medscape Education Clinical Briefs, March 2012
-
Oral Anticoagulant Therapy in Thromboembolic Disease: The Key Questions
CME Explore important clinical questions regarding the care of patients at risk for venous or arterial thromboembolic events
March 2012
-
Strategies and Clinical Insights to Reduce Stroke Risk in Atrial Fibrillation
CME Review key issues and representative cases regarding stroke prevention strategies in AF to better risk stratify and manage patients.
March 2012
-
AF Linked With Cognitive Decline, Even Without Stroke
CME A new analysis shows that atrial fibrillation is associated with an increased risk for cognitive and functional decline, regardless of the presence of stroke.
Heartwire CME, February 2012
-
Balancing Safety and Efficacy in Appropriately Selected AF Patients
CME Don’t look now but recent AF treatment guidelines are already out of date. Listen to Drs Myerburg and Connolly as they discuss how the results of PALLAS have affected the way we treat patients with AF.
Medscape Education Cardiology, February 2012
-
Direct Thrombin Inhibitors and Factor Xa Inhibitors in Patients With Cerebrovascular Disease
CME In the near future, direct thrombin inhibitors and factor Xa inhibitors are likely to replace warfarin for long-term anticoagulation in selected patients with nonvalvular atrial fibrillation.
Expert Review of Neurotherapeutics, February 2012
-
Prevention and Treatment of Venous and Arterial Thromboembolic Disease: Secondary Prevention Following ACS
CME Summarize evidence-based data and strategies to reduce residual risk in patients status post ACS
February 2012
-
New Treatment Options in the Prevention of AF-Related Stroke
CME Individualizing thromboprophylaxis in patients with AF and the role of novel oral anticoagulants are highlighted in cases presented by Dr. Lip.
Medscape Education Cardiology, January 2012
-
Silent Atrial Fibrillation Linked With Stroke Risk Increase
CME A new study finds that device-detected atrial tachyarrhythmias occur frequently and are associated with a significant increase in risk for stroke and systemic embolism.
Medscape Education Clinical Briefs, January 2012
-
Case Scenarios in AF-Related Stroke: Connecting the Dots Between Clinical Trials and Patient Care
CME Drs. Fox, Califf, Connolly, and Patel review key clinical trial data of novel oral anticoagulants, and use real-world case scenarios to discuss strategies on how to best manage patients with AF and other comorbidities.
Medscape Education Cardiology, December 2011
-
Prevention and Treatment of Venous and Arterial Thromboembolic Disease: Revisiting the Evidence Base-Stroke Prevention in Atrial Fibrillation
CME Review data from trials exploring pharmacotherapies to prevent stroke and improve outcome in patients at risk of or suffering from venous or arterial thromboembolic disease
December 2011
-
Anticoagulation Self-Monitoring Reduces Thromboembolic Risk by Half
CME Self-management of oral anticoagulation, in which patients self-tested INRs themselves and were trained to self-adjust the warfarin dose based on these results, was superior to self-testing alone.
Medscape Education Clinical Briefs, December 2011
-
Antiarrhythmics for Atrial Fibrillation: Practical Implications of Latest Clinical Developments
CME Repercussions from the surprising results from PALLAS. Drs. Camm, Connolly, and Le Heuzey discuss implications for patient care.
Medscape Education Cardiology, December 2011
-
Redefining Stroke Prevention in Atrial Fibrillation
CME Review recent data on single, dual, and triple anticoagulation therapy and, through case review and discussion, implement strategies to reduce well-documented treatment gaps in this clinical context.
December 2011
